Abstract
Clinically, ultrasound (US) has been used as a cheap, quick, and effective form of imaging that provides information useful for diagnostic purposes. With the advent of microbubbles as US contrast agents, this simple imaging technique has evolved into a tool capable of providing molecularly targeted visualization of disease and controlled delivery of therapeutics. The simple, yet robust, structure of the microbubble allows for both internal and external modifications, which lead to a wide variety of clinical uses. This chapter will introduce the reader to microbubble fabrication, stabilization, drug loading, and targeting. The reader will also be briefly exposed to specific examples of current work done using microbubbles in areas of cancer treatment and protein/gene therapies. The work reviewed here is only a small fraction of the literature available on the subject matter and serves as an introduction to microbubbles as contrast agents, drug delivery vehicles, and theranostic particles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arvanitis CD et al (2011) Cavitation-enhanced extravasation for drug delivery. Ultrasound Med Biol 37(11):1838–1852
Bekeredjian R et al (2005) Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 31(5):687–691
Bekeredjian R et al (2007) Ultrasound-targeted microbubble destruction augments proteins delivery into testes. Urology 69(2):386–389
Bioley G et al (2012) Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses. Biomaterials 33(25):5935–5946
Blomley MJ et al (2001) Microbubble contrast agents: a new era in ultrasound. BMJ 322(7296):1222–1225
Borden MA et al (2007) DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 23(18):9401–9408
Borden MA et al (2008) A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 29(5):597–606
Carson AR et al (2011) Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol 37(3):393–402
Carson AR et al (2012) Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 72(23):6191–6199
Castle J et al (2013) Ultrasound-mediated targeted drug delivery: recent success and remaining challenges. Am J Physiol Heart Circ Physiol 304(3):H350–H357
Castro-Hernandez E et al (2011) Microbubble generation in a co-flow device operated in a new regime. Lab Chip 11(12):2023–2029
Chen SY et al (2006) Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 103(22):8469–8474
Cochran MC et al (2011) Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 414(1–2):161–170
Cosgrove D (2004) The advances are significant improvements in both the microbubbles used as contrast agents and in the software that allows their selective detection. Eur Radiol 14(Suppl 8): P1–P3
Cosgrove D (2006) Ultrasound contrast agents: an overview. Eur J Radiol 60(3):324–330
Cui W et al (2005) Preparation and evaluation of poly(l-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. J Biomed Mater Res B Appl Biomater 73(1):171–178
Culp WC et al (2003) Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Interv Radiol 14(3):343–347
Deshpande N, Needles A, Willmann JK (2010) Molecular ultrasound imaging: current status and future directions. Clin Radiol 65(7):567–581
Dove JD, Murray TW, Borden MA (2013) Enhanced photoacoustic response with plasmonic nanoparticle-templated microbubbles. Soft Matter 9(32):7743–7750
Duncanson WJ et al (2010) Targeted binding of PEG-lipid modified polymer ultrasound contrast agents with tiered surface architecture. Biotechnol Bioeng 106(3):501–506
El-Aneed A (2004) An overview of current delivery systems in cancer gene therapy. J Control Release 94(1):1–14
Fabiilli ML et al (2010) Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm Res 27(12):2753–2765
Fang JY et al (2007) A study of the formulation design of acoustically active lipospheres as carriers for drug delivery. Eur J Pharm Biopharm 67(1):67–75
Feril LB et al (2006) Optimized ultrasound-mediated gene transfection in cancer cells. Cancer Sci 97(10):1111–1114
Ferrara K, Pollard R, Borden M (2007) Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9:415–447
Ganan-Calvo AM, Gordillo JM (2001) Perfectly monodisperse microbubbling by capillary flow focusing. Phys Rev Lett 87(27 Pt 1):274501
Geers B et al (2011) Self-assembled liposome-loaded microbubbles: the missing link for safe and efficient ultrasound triggered drug-delivery. J Control Release 152(2):249–256
Gunduz O et al (2012) Bioinspired bubble design for particle generation. J R Soc Interface 9(67):389–395
Hallow DM et al (2006) Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol 32(7):1111–1122
Harvey CJ et al (2001) Developments in ultrasound contrast media. Eur Radiol 11(4):675–689
Hashimoto M et al (2008) Formation of bubbles and droplets in parallel, coupled flow-focusing geometries. Small 4(10):1795–1805
Helmlinger G et al (1997) Interstitial pH and pO(2) gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3(2):177–182
Hettiarachchi K et al (2007) On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging. Lab Chip 7(4):463–468
Hettiarachchi K et al (2009) Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy. Biotechnol Prog 25(4):938–945
Huber PE, Pfisterer P (2000) In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther 7(17):1516–1525
Hynynen K et al (2001) Noninvasive MR imaging-guided focal opening of the blood–brain barrier in rabbits. Radiology 220(3):640–646
Janib SM, Moses AS, MacKay JA (2010) Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62(11):1052–1063
Kang J et al (2010) Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors. J Ultrasound Med 29(1):61–70
Kendall MR et al (2012) Scaled-up production of monodisperse, dual layer microbubbles using multi-array microfluidic module for medical imaging and drug delivery. Bubble Sci Eng Technol 4(1):12–20
Kiessling F, Huppert J, Palmowski M (2009) Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem 16(5):627–642
Kiessling F et al (2012) Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med 53(3):345–348
Kim DH, Klibanov AL, Needham D (2000) The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptor-ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated class beads. Langmuir 16(6):2808–2817
Kinoshita M, Hynynen K (2005) A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun 335(2): 393–399
Klibanov AL (1999) Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 37(1–3):139–157
Kwan JJ, Borden MA (2010) Microbubble dissolution in a multigas environment. Langmuir 26(9):6542–6548
Kwan JJ, Borden MA (2012) Lipid monolayer collapse and microbubble stability. Adv Colloid Interface Sci 183:82–99
Laurent S et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–2110
Lee MH, Lee D (2010) Elastic instability of polymer-shelled bubbles formed from air-in-oil-in-water compound bubbles. Soft Matter 6(18):4326–4330
Lee H et al (2006) Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 128(22):7383–7389
Lentacker I et al (2006) Microbubbles which bind and protect DNA against nucleases. J Control Release 116(2):E73–E75
Lentacker I et al (2007) Lipoplex-loaded microbubbles for gene delivery: a Trojan horse controlled by ultrasound. Adv Funct Mate 17(12):1910–1916
Lentacker I et al (2010) Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 18(1):101–108
Leong-Poi H et al (2007) Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res 101(3):295–303
Li YS et al (2009) Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett 273(1):62–69
Lin CY et al (2012) Enhancement of focused ultrasound with microbubbles on the treatments of anticancer nanodrug in mouse tumors. Nanomedicine 8(6):900–907
Liu Z et al (2011) Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 32(26):6155–6163
Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207
Maeda H et al (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65(1–2):271–284
Martinez J et al (2002) Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110(5):563–574
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17(5):545–580
Mesiwala AH, Mourad PD (2002) Monitoring of biologic effects of focused ultrasound beams on the brain. Radiology 224(1):294–296, author reply 296–7
Mesiwala AH et al (2002) High-intensity focused ultrasound selectively disrupts the blood–brain barrier in vivo. Ultrasound Med Biol 28(3):389–400
Miller DL, Pislaru SV, Greenleaf JE (2002) Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 27(1–6):115–134
Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9(24):1647–1652
Nisisako T, Torii T (2008) Microfluidic large-scale integration on a chip for mass production of monodisperse droplets and particles. Lab Chip 8(2):287–293
Panje CM et al (2012) Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics 2(11):1078–1091
Paradossi G et al (2003) Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications. J Mater Sci Mater Med 14(8):687–691
Parhizkar M, Edirisinghe M, Stride E (2013) Effect of operating conditions and liquid physical properties on the size of monodisperse microbubbles produced in a capillary embedded T-junction device. Microfluid Nanofluidics 14(5):797–808
Park Y et al (2012) Tunable diacetylene polymerized shell microbubbles as ultrasound contrast agents. Langmuir 28(8):3766–3772
Phillips P, Gardner E (2004) Contrast-agent detection and quantification. Eur Radiol 14(Suppl 8): P4–P10
Pochon S et al (2010) BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45(2):89–95
Porter TR, Xie F (2001) Ultrasound, microbubbles, and thrombolysis. Prog Cardiovasc Dis 44(2):101–110
Porter TR et al (1996) Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J 132(5):964–968
Pramanik M et al (2008) Design and evaluation of a novel breast cancer detection system combining both thermoacoustic (TA) and photoacoustic (PA) tomography. Med Phys 35(6):2218–2223
Rapoport N, Gao Z, Kennedy A (2007) Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99(14):1095–1106
Romanowsky MB et al (2012) High throughput production of single core double emulsions in a parallelized microfluidic device. Lab Chip 12(4):802–807
Roth JA, Cristiano RJ (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89(1):21–39
Sarkar K, Katiyar A, Jain P (2009) Growth and dissolution of an encapsulated contrast microbubble: effects of encapsulation permeability. Ultrasound Med Biol 35(8):1385–1396
Sciallero C, Trucco A (2013) Ultrasound assessment of polymer-shelled magnetic microbubbles used as dual contrast agents. J Acoust Soc Am 133(6):El478–El484
Sever AR et al (2012) Sentinel node identification using microbubbles and contrast-enhanced ultrasonography. Clin Radiol 67(7):687–694
Sheikov N et al (2004) Cellular mechanisms of the blood–brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 30(7):979–989
Sheikov N et al (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34(7):1093–1104
Shortencarier MJ et al (2004) A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control 51(7):822–831
Stride E, Saffari N (2003) Microbubble ultrasound contrast agents: a review. Proc Inst Mech Eng H 217(6):429–447
Talu E et al (2007) Tailoring the size distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular imaging. Mol Imaging 6(6):384–392
Tardy I et al (2010) Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol 45(10):573–578
Tinkov S et al (2010a) New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release 148(3):368–372
Tinkov S et al (2010b) New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I – Formulation development and in-vitro characterization. J Control Release 143(1):143–150
Treat LH et al (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood–brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38(10):1716–1725
Unger EC et al (1998) Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33(12):886–892
Unger EC et al (2001) Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 44(1):45–54
Unger EC et al (2004) Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 56(9):1291–1314
Urban-Klein B et al (2005) RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 12(5):461–466
Villa R et al (2013) Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells. Colloids Surf B Biointerfaces 110:434–442
Willmann JK et al (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246(2):508–518
Xu MH, Wang LHV (2006) Photoacoustic imaging in biomedicine. Rev Sci Instrum 77(4):1–22
Xu JH et al (2012) Controllable gas/liquid/liquid double emulsions in a dual-coaxial microfluidic device. Lab Chip 12(11):2029–2036
Yan Y et al (2011) Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1. Cardiovasc Res 89(1):175–183
Yan F et al (2013) Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release 166(3):246–255
Yang F et al (2009) Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 30(23–24):3882–3890
Acknowledgments
J. Y. W. acknowledges support from Boston University’s College of Engineering Distinguished Faculty Fellowship, T. P. acknowledges support from the NIH/NIGMS T32 GM008764 and the NIH/NIAID T32 AI089673, and C. B. acknowledges support from the National Science Foundation Graduate Research Fellowship Program.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Controlled Release Society
About this chapter
Cite this chapter
Pham, T., Beigie, C., Park, Y., Wong, J.Y. (2014). Microbubbles as Theranostics Agents. In: Alonso, M., Garcia-Fuentes, M. (eds) Nano-Oncologicals. Advances in Delivery Science and Technology. Springer, Cham. https://doi.org/10.1007/978-3-319-08084-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-08084-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08083-3
Online ISBN: 978-3-319-08084-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)